The Epoch Times
The Epoch Times
Focus

CoronaVac

Vaccines & Safety
Vaccines & Safety
|
Lisa Lin

BioNTech and Sinovac Vaccines Less Effective Against Omicron: Study

Sep 19, 2022
|
Lisa Lin
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
BioNTech and Sinovac Vaccines Less Effective Against Omicron: Study
Sep 19
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Vaccines & Safety
Vaccines & Safety
|
Rita Li

87 Percent of Immunized Who Died of COVID-19 in Hong Kong Got Chinese-Made Vaccine: Report

Mar 21, 2022
|
Rita Li
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
87 Percent of Immunized Who Died of COVID-19 in Hong Kong Got Chinese-Made Vaccine: Report
Mar 21
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
INSIDE CHINA
INSIDE CHINA
|
Dorothy Li

Fully Vaccinated Chinese Workers Test Positive for COVID-19 in Southern Shenzhen City

May 28, 2021
|
Dorothy Li
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Fully Vaccinated Chinese Workers Test Positive for COVID-19 in Southern Shenzhen City
May 28
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Chinese Regime
Chinese Regime
|
Eva Fu

China Eases Visa Rules to Entice Visitors to Take Homegrown Vaccines

Mar 15, 2021
|
Eva Fu
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
China Eases Visa Rules to Entice Visitors to Take Homegrown Vaccines
Mar 15
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
INSIDE CHINA
INSIDE CHINA
|
Alex Wu

Doctors and Residents in Beijing Reject Chinese-made COVID-19 Vaccines

Jan 28, 2021
|
Alex Wu
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Doctors and Residents in Beijing Reject Chinese-made COVID-19 Vaccines
Jan 28
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Social Issues
Social Issues
|
Frank Yue

China Only Allows People 18 to 59 to Take COVID-19 Vaccines

Jan 14, 2021
|
Frank Yue
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
China Only Allows People 18 to 59 to Take COVID-19 Vaccines
Jan 14
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
WORLD
WORLD
|
Eva Fu

Chinese COVID-19 Vaccine Shows 50.4 Percent Efficacy in Brazil Trial

Jan 13, 2021
|
Eva Fu
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Chinese COVID-19 Vaccine Shows 50.4 Percent Efficacy in Brazil Trial
Jan 13
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.